Use the search parameters below to filter talks:

Calendar
Calendar

2009 - ISBTS (ITA) (Bologna)

Room B
10 September 2009  /  10:30 - 12:30

DECREASED INCIDENCE AND MORTALITY OF POST TRANSPLANT LYMPHO PROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC INTESTINAL TRANSPLANTATION (PITX) RECEIVING RATG AND ALEMTUZUMAB IMMUNOSUPPRESSION

Presenter: Ran Tao, Pittsburgh, USA

- DECREASED INCIDENCE AND MORTALITY OF POST TRANSPLANT LYMPHO PROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC INTESTINAL TRANSPLANTATION (PITX) RECEIVING RATG AND ALEMTUZUMAB IMMUNOSUPPRESSION

Presenter: Ran Tao, Pittsburgh, USA

INFLIXIMAB AS SALVAGE THERAPY FOR STEROID AND THYMOGLOBULIN RESISTANT LATE ACUTE INTESTINAL REJECTION IN PEDIATRIC INTESTINAL TRANSPLANT RECIPIENTS

Presenter: E De Greef, Toronto, Canada

- INFLIXIMAB AS SALVAGE THERAPY FOR STEROID AND THYMOGLOBULIN RESISTANT LATE ACUTE INTESTINAL REJECTION IN PEDIATRIC INTESTINAL TRANSPLANT RECIPIENTS

Presenter: E De Greef, Toronto, Canada

INFLUENCE OF ANTI-MICROBIAL PEPTIDES ON OUTCOMES IN HUMAN INTESTINAL TRANSPLANTS WITH COLONIC INCLUSION

Presenter: C Matsumoto, Washington, USA

- INFLUENCE OF ANTI-MICROBIAL PEPTIDES ON OUTCOMES IN HUMAN INTESTINAL TRANSPLANTS WITH COLONIC INCLUSION

Presenter: C Matsumoto, Washington, USA

VIROLOGICAL MONITORING (EARLY AND LATE PERIOD) OF CMV, EBV AND HHV-6 INFECTIONS IN SMALL BOWEL/MULTIVISCERAL TRANSPLANTATION.

Presenter: E Petrisli, Bologna, Italy

- VIROLOGICAL MONITORING (EARLY AND LATE PERIOD) OF CMV, EBV AND HHV-6 INFECTIONS IN SMALL BOWEL/MULTIVISCERAL TRANSPLANTATION.

Presenter: E Petrisli, Bologna, Italy

DACLIZUMAB AND ALEMTUZUMAB AS INDUCTION AGENTS IN ADULT INTESTINAL AND MULTIVISCERAL TRANSPLANTATION: REJECTIONS AND INFECTIONS ON 40 RECIPIENTS DURING THE EARLY POST-OPERATIVE PERIOD.

Presenter: C. Zanfi, Bologna, Italy

- DACLIZUMAB AND ALEMTUZUMAB AS INDUCTION AGENTS IN ADULT INTESTINAL AND MULTIVISCERAL TRANSPLANTATION: REJECTIONS AND INFECTIONS ON 40 RECIPIENTS DURING THE EARLY POST-OPERATIVE PERIOD.

Presenter: C. Zanfi, Bologna, Italy

LONG-TERM EXPERIENCE IN PATIENTS RECEIVING INFLIXIMAB

Presenter: Undine A Gerlach, Berlin, Germany

- LONG-TERM EXPERIENCE IN PATIENTS RECEIVING INFLIXIMAB

Presenter: Undine A Gerlach, Berlin, Germany

ROUTINE USE OF EARLY INTRAVENOUS TACROLIMUS IN INTESTINAL TRANSPLANTATION MAINTAINS MORE CONSISTENT BLOOD LEVELS WITHOUT NEGATIVELY IMPACTING RENAL FUNCTION

Presenter: RS Mangus, Indianapolis, USA

- ROUTINE USE OF EARLY INTRAVENOUS TACROLIMUS IN INTESTINAL TRANSPLANTATION MAINTAINS MORE CONSISTENT BLOOD LEVELS WITHOUT NEGATIVELY IMPACTING RENAL FUNCTION

Presenter: RS Mangus, Indianapolis, USA

THROMBOTIC MICRO-ANGIOPATHY FOLLOWING INTESTINAL OR MULTIVISCERAL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Presenter: Daan Dierickx, Leuven, Belgium

- THROMBOTIC MICRO-ANGIOPATHY FOLLOWING INTESTINAL OR MULTIVISCERAL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Presenter: Daan Dierickx, Leuven, Belgium

INCIDENCE AND TIMING OF ADENOVIRUS INFECTIONS IN PEDIATRIC SMALL BOWEL TRANSPLANTATION

Presenter: DF Florescu, Omaha, USA

- INCIDENCE AND TIMING OF ADENOVIRUS INFECTIONS IN PEDIATRIC SMALL BOWEL TRANSPLANTATION

Presenter: DF Florescu, Omaha, USA

INCIDENCE OF FUNGAL INFECTIONS IN PEDIATRIC SMALL BOWEL RECIPIENTS

Presenter: DF Florescu, Omaha, USA

- INCIDENCE OF FUNGAL INFECTIONS IN PEDIATRIC SMALL BOWEL RECIPIENTS

Presenter: DF Florescu, Omaha, USA

RISK STRATIFICATION OF CYTOMEGALOVIRUS DISEASE IN INTESTINAL TRANSPLANTATION

Presenter: R. Girlanda, Washington DC, USA

- RISK STRATIFICATION OF CYTOMEGALOVIRUS DISEASE IN INTESTINAL TRANSPLANTATION

Presenter: R. Girlanda, Washington DC, USA

Is the development of immune-suppressor therapy changing the histology in graft pathology?
11 September 2009  /  16:30 - 18:00

Is the development of immune-suppressor therapy changing the histology in graft pathology?

Presenter: Galen Cortina, Los Angeles, USA

- Is the development of immune-suppressor therapy changing the histology in graft pathology?

Presenter: Galen Cortina, Los Angeles, USA

Is the development of immune-suppressor therapy changing the histology in graft pathology?

Presenter: Tong Wu, Pittsburgh, USA

- Is the development of immune-suppressor therapy changing the histology in graft pathology?

Presenter: Tong Wu, Pittsburgh, USA

Room B
10 September 2009  /  14:00 - 16:00

CORRELATION OF BIOMARKERS WITH REJECTION EPISODES IN SMALL BOWEL TRANSPLANT.

Presenter: Philip Ruiz, Miami, USA

- CORRELATION OF BIOMARKERS WITH REJECTION EPISODES IN SMALL BOWEL TRANSPLANT.

Presenter: Philip Ruiz, Miami, USA

IS STOMAL BIOPSY ADEQUATE TO MONITOR FOR COMPLICATIONS IN THE PERI-INTESTINAL TRANSPLANT PERIOD?

Presenter: F Tagliabue, Birmingham, United Kingdom

- IS STOMAL BIOPSY ADEQUATE TO MONITOR FOR COMPLICATIONS IN THE PERI-INTESTINAL TRANSPLANT PERIOD?

Presenter: F Tagliabue, Birmingham, United Kingdom

FREE PLASMATIC DNA AS A BIOMARKER FOR INTESTINAL TRANSPLANTATION RECIPIENTS: QUANTIFICATION AND MICROCHIMERIC ANALYSIS

Presenter: Annalisa Altimari, Bologna, Italy

- FREE PLASMATIC DNA AS A BIOMARKER FOR INTESTINAL TRANSPLANTATION RECIPIENTS: QUANTIFICATION AND MICROCHIMERIC ANALYSIS

Presenter: Annalisa Altimari, Bologna, Italy

ACUTE GRAFT REJECTION AND EBV INFECTION AFTER SMALL BOWEL TRANSPLANT (ITX) ARE ASSOCIATED WITH CHANGES IN PERIPHERAL-BLOOD LYMPHOCYTE SUBSETS (PLS)

Presenter: D Dell-Olio, Birmingham, United Kingdom

- ACUTE GRAFT REJECTION AND EBV INFECTION AFTER SMALL BOWEL TRANSPLANT (ITX) ARE ASSOCIATED WITH CHANGES IN PERIPHERAL-BLOOD LYMPHOCYTE SUBSETS (PLS)

Presenter: D Dell-Olio, Birmingham, United Kingdom

C4D DEPOSITION IS HIGHLY PREVALENT IN BOTH MUCOSAL AND SUBMUCOSAL VASCULATURE OF INTESTINAL ALLOGRAFT BIOPSIES

Presenter: Evelyne Lerut, Leuven, Belgium

- C4D DEPOSITION IS HIGHLY PREVALENT IN BOTH MUCOSAL AND SUBMUCOSAL VASCULATURE OF INTESTINAL ALLOGRAFT BIOPSIES

Presenter: Evelyne Lerut, Leuven, Belgium

FAECAL CALPROTECTIN IS A NON-INVASIVE MARKER OF INFLAMMATION BUT NOT ALLOGRAFT REJECTION FOLLOWING INTESTINAL TRANSPLANTATION

Presenter: J Hind, Birmingham, United Kingdom

- FAECAL CALPROTECTIN IS A NON-INVASIVE MARKER OF INFLAMMATION BUT NOT ALLOGRAFT REJECTION FOLLOWING INTESTINAL TRANSPLANTATION

Presenter: J Hind, Birmingham, United Kingdom

GRANZYME B, PERFORIN AND FAS LIGAND BLOOD EXPRESSION FOR THE MONITORING OF INTESTINAL TRANSPLANTATION RECIPIENTS

Presenter: Annalisa Altimari, Bologna, Italy

- GRANZYME B, PERFORIN AND FAS LIGAND BLOOD EXPRESSION FOR THE MONITORING OF INTESTINAL TRANSPLANTATION RECIPIENTS

Presenter: Annalisa Altimari, Bologna, Italy

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi